Navigation Links
Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
Date:2/5/2008

Present additional data from the completed Phase 1b study designed to

evaluate the effect of a single administration of SB-509 in subjects

with mild to moderate DN.

-- Complete follow-up and presentation of data in the second half of the

year from a Phase 2 study (SB-509-601) to evaluate the effects of

SB-509 in subjects with mild to moderate DN.

-- Complete accrual, follow-up and presentation of data from a Phase 2

study (SB-509-701) to evaluate SB-509 in subjects with moderate to

severe DN.

-- Complete accrual and treatment in the recently initiated Phase 2

pharmacokinetic trial (SB-509-703) to evaluate the effect of SB-509 on

stem cell mobilization

-- Initiate a Phase 2 clinical trial to evaluate SB-509 for the treatment

of ALS (Amyotrophic Lateral Sclerosis, also known as "Lou Gehrig's

disease").

-- Advance ZFP Therapeutic pipeline by initiating Phase 1 clinical trials

of ZFP Therapeutics for glioblastoma and HIV / CCR5.

-- Present preclinical data in spinal cord injury, stroke, neuropathic

pain and ZFN(TM)-mediated gene modification.

Business -- Strategic Collaborations & Enabling Technology Agreements

-- Pursue strategic partnering in ZFP Therapeutics.

-- Achieve additional research milestones in Dow AgroSciences

collaboration in plant agriculture.

-- Increase visibility and value of ZFNs by developing commercial

research reagents in collaboration with Sigma-Aldrich.

-- Establish new commercial license agreements using ZFNs to improve

cell-lines used in protein production and other biological

applications.

Financials and Operations

-- Maintain year-end 2008 cash and investments balance of at least $55.0

million.

Conference Call

Sangamo will host a conference call today at 5:00 p.m. ET, w
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
4. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
5. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
6. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
7. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
8. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
9. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Since last month,s FBI shutdown ... known as the leading online black market for illegal ... in its offering of drugs and other illegal items.  ... takedowns did succeed in lowering the numbers of drugs ... the markets in August. But some new sites that ...
(Date:12/19/2014)... LYON, France , Dec. 19, 2014 /PRNewswire/ ... and Adocia (Euronext Paris: FR0011184241 – ADOC) today announced ... insulin, known as BioChaperone Lispro, for treatment in people ... relies on Adocia,s proprietary BioChaperone® technology and is currently ... will develop BioChaperone Lispro with the goal of optimizing ...
(Date:12/17/2014)... , Dec. 17, 2014 Royal Philips ... Corporation (NASDAQ: VOLC ), a global leader in ... that they have entered into a definitive merger agreement. Pursuant ... acquire all of the issued and outstanding shares of Volcano ... price of USD 1 billion (approx. EUR 800 million), to ...
Breaking Medicine Technology:Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... 23, 2007 - Synta,Pharmaceuticals Corp., (NASDAQ: SNTA) ... commercializing small,molecule drugs to treat severe medical ... from the Phase 2b clinical,trial in metastatic ... STA-4783, will be presented at the annual ...
... - Bentley,Pharmaceuticals, Inc. (NYSE: BNT), a specialty ... abstract sponsored by,the Company has been accepted ... Association 67th Scientific Sessions in Chicago.,The abstract, ... Comparison Study of Intranasal Insulin Spray,(Nasulin(TM)) and ...
Cached Medicine Technology:Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions 2Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions 3
(Date:12/21/2014)... The Oncology Institute of Hope and Innovation hosted ... Whittier offices. The Hope for the Holidays Toy Drive is ... their families during the holiday season. This year, the toy ... between both offices. This event continues to be successful year ... team, store managers and assistant managers came out and not ...
(Date:12/20/2014)... BambooIndustry.com is a professional company offering many kinds ... shown its new engineered bamboo flooring collection, and announced ... , BambooIndustry.com’s customers come from many countries in the ... the CEO of the company, the global bamboo flooring ... few years, and the demand for eco-friendly bamboo flooring ...
(Date:12/20/2014)... (PRWEB) December 21, 2014 MissyDress, a ... for all prom lovers. The business has drastically cut ... prom dresses to everyone until Jan. 30, 2015. Many ... dresses, sweetheart dresses, V-neck dresses, lace dresses, and more. ... are not there every day. Whether A-line princess prom ...
(Date:12/20/2014)... 20, 2014 An improving macroeconomic landscape ... benefited the Massage Services industry over the ... industry products, the anticipated 1.0% annualized increase in per ... consumers with the means to afford additional massages. “While ... massage in a given year has declined from 2009 ...
(Date:12/20/2014)... December 20, 2014 DePuy Pinnacle ... metal-on-metal version of the artificial hip system was ... and federal courts, Bernstein Liebhard LLP reports. According ... County Superior Court on December 2nd, counsel in ... deposition of plaintiffs on November 19, 2014, with ...
Breaking Medicine News(10 mins):Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4
... due to packaging and sound-alike drug,names, HARRISBURG, ... high (23%) in the number of reports submitted ... Patient Safety,Authority highlights the common causes of drug ... Unclear and confusing labeling and packaging as well ...
... Walk to School Day is October 3, 2007, ... schoolchildren from all 50 states will join thousands across ... lifestyles by walking,or bicycling to school on International Walk ... more and more schools are,holding Walk to School Day ...
... children are protected when shopping at a store using ... bacteria on shopping carts, GREEN BAY, Wis., Sept. ... to be an iParenting Media Award Winner for 2007,Outstanding ... its 2007 Outstanding Products Call for Entries, and all ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) announced ... Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg, ... tablets, 600 mg), an expectorant,indicated to relieve chest ... approximately $120 million through food, drug and mass,merchandisers ...
... will host a question and answer session on its ... today. During the company,s long term,care conference call earlier ... from accessing the Q & A session that was ... conference call, dial (888) 251-7470 and use the,Conference ID ...
... Both USDA Organic & Fair Trade Certified(TM), FORT ... to providing body care products that enhance the health,and ... launched an,innovative and earth friendly way to package their ... size products, is made entirely from,100% U.S. grown corn, ...
Cached Medicine News:Health News:Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors 2Health News:Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors 3Health News:Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors 4Health News:Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors 5Health News:Children Around the Globe Walk Toward a Lifetime of Healthy Habits 2Health News:PureCart Systems of Green Bay, Wis., is an Honored Recipient of an iParenting Media Award 2Health News:Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory 2Health News:Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory 3Health News:BeeCeuticals Organics Introduces First Dual Certified Body Care Product and Eco-Friendly Packaging Made from Corn 2Health News:BeeCeuticals Organics Introduces First Dual Certified Body Care Product and Eco-Friendly Packaging Made from Corn 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: